• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Leukemia, Myeloid, Chronic-Phase

Leukemia, Myeloid, Chronic-Phase - 25 Studies Found

Completed : PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML
: Chronic Myeloid Leukemia
: 2006-03-15
:
  • Drug: Peg Interferon Alpha 2b (Peg Intron)

Completed : Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment
: Leukemia
: 2003-11-04
: Biological: sargramostim
Withdrawn : Arsenic Trioxide in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Has Not Responded to Previous Treatment
: Leukemia
: 2000-08-03
: Drug: arsenic trioxide
Completed : BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate
: Leukemia
: 2003-07-08
: Drug: dasatinib
Completed : A Study Comparing Ponatinib and Nilotinib in Patients With Chronic Myeloid Leukemia
: Chronic Phase Chronic Myeloid Leukemia
: 2015-08-13
:
  • Drug: ponatinib 30 mg QD ponat

<<< Previous
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.